|
Piramal Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
26896.01 Cr.
|
P/BV
|
3.40
|
Book Value (Rs.)
|
59.53
|
|
52 Week High/Low (Rs.)
|
308/182
|
FV/ML
|
10/1
|
P/E(X)
|
295.39
|
|
Bookclosure
|
16/07/2025
|
EPS (Rs.)
|
0.69
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 9061.00 | 8106.41 | 6976.83 | 6430.77 | 6270.28 |
| Other Operating Revenues | 90.18 | 64.75 | 104.72 | 128.33 | 44.62 |
| Total Operating Revenues | 9151.18 | 8171.16 | 7081.55 | 6559.10 | 6314.90 |
| | | | | | |
| Other Income | 134.81 | 175.39 | 225.11 | 275.80 | 164.11 |
| Total Revenue | 9285.99 | 8346.55 | 7306.66 | 6834.90 | 6479.01 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 2055.74 | 1976.83 | 1682.46 | 1566.96 | 1560.22 |
| Purchase Of Stock-In Trade | 1417.32 | 1175.77 | 952.20 | 829.07 | 551.63 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -241.41 | -198.60 | 68.64 | 55.21 | -52.74 |
| Employee Benefit Expenses | 2307.47 | 2029.50 | 1896.35 | 1588.83 | 1467.74 |
| Finance Costs | 421.59 | 448.49 | 344.18 | 198.25 | 163.45 |
| Depreciation And Amortisation Expenses | 816.34 | 740.57 | 676.69 | 586.18 | 545.04 |
| Other Expenses | 2167.23 | 1991.40 | 1853.66 | 1569.37 | 1360.09 |
| Total Expenses | 8944.28 | 8163.96 | 7474.18 | 6393.87 | 5595.43 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 341.71 | 182.59 | -167.52 | 441.03 | 883.58 |
| | | | | | |
| Exceptional Items | 0.00 | -62.79 | -6.96 | -15.08 | 18.23 |
| Profit/Loss Before Tax | 341.71 | 119.80 | -174.48 | 425.95 | 901.81 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 310.12 | 185.35 | 110.40 | 191.13 | 116.34 |
| Deferred Tax | 13.39 | -23.88 | -44.09 | -82.11 | -2.32 |
| Total Tax Expenses | 323.51 | 161.47 | 66.31 | 109.02 | 114.02 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 18.20 | -41.67 | -240.79 | 316.93 | 787.79 |
| | | | | | |
| Profit/Loss From Continuing Operations | 18.20 | -41.67 | -240.79 | 316.93 | 787.79 |
| | | | | | |
| Profit/Loss For The Period | 18.20 | -41.67 | -240.79 | 316.93 | 787.79 |
| Share Of Profit/Loss Of Associates | 72.93 | 59.49 | 54.33 | 59.03 | 47.24 |
| Consolidated Profit/Loss After MI And Associates | 91.13 | 17.82 | -186.46 | 375.96 | 835.03 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 0.69 | 0.14 | -1.57 | 3.19 | 18.56 |
| Diluted EPS (Rs.) | 0.68 | 0.14 | -1.57 | 3.19 | 18.56 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 14.47 | 0.00 | 0.00 | 0.00 | 0.00 |
